U.S. stocks remained mostly lower in midday trading on Tuesday as investors weighed concerns around President Donald Trump’s tariff plans and [the health of the U.S. consumer.]( ...
Metsera Inc. (MTSR), a New York-based biotech that went public on Jan. 31 with some fanfare, has a full portfolio of weight-loss drugs in development, using both the hormones already used in existing ...
Wall Street is falling again Tuesday as U.S. households get more pessimistic about the economy because of inflation, tariffs ...
We recently published a list of 10 Stocks Drop The Most Amid Investor Caution. In this article, we are going to take a look ...